HomeERIS • NSE
add
Eris Lifesciences Ltd
Previous close
₹1,590.60
Day range
₹1,564.50 - ₹1,597.90
Year range
₹1,097.20 - ₹1,910.00
Market cap
214.00B INR
Avg Volume
208.67K
P/E ratio
51.60
Dividend yield
0.47%
Primary exchange
NSE
Market news
The Globe and Mail
8 hours ago
PesoRama Secures TSXV Approval for Equity Financing with Clarifications
1.96%
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 7.90B | 6.93% |
Operating expense | 3.69B | -0.01% |
Net income | 1.20B | 31.23% |
Net profit margin | 15.21 | 22.76% |
Earnings per share | 8.81 | 31.10% |
EBITDA | 2.89B | 10.18% |
Effective tax rate | 22.12% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 747.50M | -69.18% |
Total assets | 71.60B | 1.97% |
Total liabilities | 36.56B | -4.90% |
Total equity | 35.03B | — |
Shares outstanding | 136.27M | — |
Price to book | 7.01 | — |
Return on assets | — | — |
Return on capital | 9.41% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 1.20B | 31.23% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2007
Website
Employees
3,354
